One of two pneumonia drugs offers longer-term protection for COPD patients, study finds
Aug 06, 2021
The two available pneumonia vaccines recommended for older adults are equally good at safeguarding the health of people with chronic obstructive pulmonary disease. But Prevnar13 appears to offer longer-term...
Clinical briefs for Tuesday, June 15
Jun 15, 2021
CMS issues reprieve for 2,500 nursing homes yet to report COVID vaccination rates … Former CMS administrator says nursing homes will remain key test sites for COVID therapies, other treatments …...
40 percent of US older adults with COPD have poor access to pulmonary rehabilitation
May 20, 2021
Approximately 40% of Medicare beneficiaries with chronic obstructive pulmonary disease have limited access to pulmonary rehabilitation services due to their distance from rehab centers. That’s according...
NIH: Inhaled moisturizing drug boosts lung function in severe COPD
Feb 02, 2021
The biologic drug hyaluronan improved lung function in patients hospitalized for severe exacerbation of chronic obstructive pulmonary disease, a new study finds.
Additional pulmonary rehab sessions boost survival in COPD post-acute care
May 12, 2020
Starting pulmonary rehab within 90 days of hospitalization for COPD has significant survival benefits. More sessions further improve patient outcomes.
Breathing difficulty, COPD, point to greatest risk in early-stage coronavirus
Mar 23, 2020
Among coronavirus symptoms, breathing difficulties are significantly tied to severe illness progression and ICU admission, say investigators.
Clinical Briefs for Friday, March 20
Mar 19, 2020
Three-drug combination reduces all-cause COPD mortality by 42% … COVID-19 death rate lower than estimated, at 1.4% in outbreak epicenter … FDA: Stop SLGT2 inhibitors for diabetes prior to surgery
Proposed diagnostics criteria could swell COPD diagnoses, care
Nov 12, 2019
Leading medical institutions are proposing new diagnostic criteria for chronic obstructive pulmonary disease, the nation’s fourth leading cause of death.
COPD patients discharged to a skilled nursing facility are twice as likely to die within a year
Nov 06, 2014
People who go to a skilled nursing facility after being hospitalized for chronic obstructive pulmonary disease are about twice as likely to die within a year, according to recently released findings.
FDA approves Anoro Ellipta
Dec 20, 2013
The U.S. Food and Drug Administration have approved GlaxoSmithKline’s Anoro™ Ellipta™, the company announced. The product is used to treat chronic obstructive pulmonary disease.